| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Technology, Radiologic | 14 | 2024 | 103 | 4.650 |
Why?
|
| ROC Curve | 30 | 2020 | 752 | 3.770 |
Why?
|
| Radiographic Image Enhancement | 19 | 2022 | 462 | 3.740 |
Why?
|
| Diagnosis, Computer-Assisted | 19 | 2024 | 332 | 3.130 |
Why?
|
| Societies, Scientific | 5 | 2022 | 44 | 2.700 |
Why?
|
| Image Processing, Computer-Assisted | 15 | 2023 | 1204 | 2.670 |
Why?
|
| Tomography, X-Ray Computed | 21 | 2024 | 2601 | 2.650 |
Why?
|
| Radiography, Thoracic | 19 | 2013 | 320 | 2.290 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 24 | 2013 | 466 | 2.260 |
Why?
|
| Mammography | 14 | 2020 | 463 | 2.200 |
Why?
|
| Radiology | 7 | 2022 | 194 | 1.880 |
Why?
|
| Phantoms, Imaging | 10 | 2023 | 429 | 1.770 |
Why?
|
| Software | 11 | 2019 | 654 | 1.750 |
Why?
|
| Subtraction Technique | 10 | 2013 | 133 | 1.700 |
Why?
|
| Whole Body Imaging | 5 | 2011 | 41 | 1.390 |
Why?
|
| Radiation Dosage | 6 | 2023 | 227 | 1.390 |
Why?
|
| Bone and Bones | 5 | 2011 | 265 | 1.270 |
Why?
|
| Artificial Intelligence | 9 | 2020 | 298 | 1.220 |
Why?
|
| Lung Neoplasms | 18 | 2021 | 2262 | 1.170 |
Why?
|
| Pattern Recognition, Automated | 13 | 2015 | 217 | 1.150 |
Why?
|
| Ultrasonography | 8 | 2016 | 695 | 1.130 |
Why?
|
| Thorax | 2 | 2022 | 75 | 1.000 |
Why?
|
| Computer Simulation | 4 | 2018 | 1078 | 0.990 |
Why?
|
| Diagnostic Imaging | 4 | 2012 | 469 | 0.960 |
Why?
|
| Receptors, Somatostatin | 1 | 2024 | 33 | 0.960 |
Why?
|
| Solitary Pulmonary Nodule | 13 | 2013 | 138 | 0.960 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2019 | 3362 | 0.930 |
Why?
|
| Observer Variation | 25 | 2019 | 602 | 0.910 |
Why?
|
| Radionuclide Imaging | 5 | 2024 | 220 | 0.840 |
Why?
|
| Liver Neoplasms | 7 | 2016 | 736 | 0.800 |
Why?
|
| Biomedical Research | 3 | 2017 | 376 | 0.790 |
Why?
|
| Algorithms | 16 | 2023 | 1830 | 0.770 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2020 | 12 | 0.770 |
Why?
|
| Image Interpretation, Computer-Assisted | 6 | 2015 | 663 | 0.770 |
Why?
|
| Neuropeptide Y | 1 | 2020 | 31 | 0.760 |
Why?
|
| Hyperphagia | 1 | 2020 | 35 | 0.760 |
Why?
|
| Dipeptides | 1 | 2020 | 46 | 0.750 |
Why?
|
| Sensitivity and Specificity | 27 | 2015 | 1991 | 0.750 |
Why?
|
| Hypothalamus | 1 | 2020 | 79 | 0.740 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2016 | 384 | 0.730 |
Why?
|
| Reading | 1 | 2020 | 30 | 0.720 |
Why?
|
| Eating | 1 | 2020 | 166 | 0.700 |
Why?
|
| Oxides | 4 | 2012 | 43 | 0.680 |
Why?
|
| Image Enhancement | 7 | 2016 | 563 | 0.680 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2019 | 24 | 0.680 |
Why?
|
| Ferric Compounds | 4 | 2012 | 38 | 0.680 |
Why?
|
| Iron | 4 | 2012 | 164 | 0.650 |
Why?
|
| Humans | 78 | 2021 | 86643 | 0.650 |
Why?
|
| Mass Chest X-Ray | 1 | 2018 | 6 | 0.640 |
Why?
|
| Brain | 7 | 2019 | 2216 | 0.630 |
Why?
|
| Calcinosis | 6 | 2011 | 224 | 0.630 |
Why?
|
| Awards and Prizes | 3 | 2024 | 36 | 0.630 |
Why?
|
| Radiography, Abdominal | 1 | 2018 | 71 | 0.620 |
Why?
|
| Patient Positioning | 1 | 2017 | 63 | 0.590 |
Why?
|
| Signal-To-Noise Ratio | 4 | 2020 | 96 | 0.590 |
Why?
|
| Learning | 2 | 2021 | 280 | 0.590 |
Why?
|
| Diagnostic Errors | 2 | 2017 | 160 | 0.580 |
Why?
|
| Radiation Exposure | 1 | 2016 | 24 | 0.580 |
Why?
|
| Bone Neoplasms | 2 | 2011 | 322 | 0.570 |
Why?
|
| Alzheimer Disease | 3 | 2018 | 470 | 0.570 |
Why?
|
| Knee Joint | 1 | 2017 | 168 | 0.560 |
Why?
|
| User-Computer Interface | 4 | 2012 | 185 | 0.560 |
Why?
|
| Codes of Ethics | 1 | 2016 | 12 | 0.560 |
Why?
|
| Safety | 1 | 2016 | 152 | 0.550 |
Why?
|
| Data Mining | 1 | 2016 | 42 | 0.540 |
Why?
|
| Congresses as Topic | 1 | 2016 | 116 | 0.530 |
Why?
|
| Accidents | 1 | 2015 | 8 | 0.520 |
Why?
|
| Pandemics | 1 | 2021 | 740 | 0.500 |
Why?
|
| Language | 1 | 2016 | 151 | 0.500 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 1313 | 0.490 |
Why?
|
| Gadolinium DTPA | 2 | 2012 | 261 | 0.480 |
Why?
|
| Breast Diseases | 3 | 2009 | 97 | 0.480 |
Why?
|
| Breast Neoplasms | 11 | 2012 | 2903 | 0.480 |
Why?
|
| Time Factors | 1 | 2023 | 5210 | 0.470 |
Why?
|
| Abbreviations as Topic | 1 | 2013 | 1 | 0.470 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2012 | 579 | 0.470 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2019 | 318 | 0.460 |
Why?
|
| Technology | 2 | 2024 | 29 | 0.460 |
Why?
|
| Research Report | 1 | 2013 | 44 | 0.450 |
Why?
|
| Aged | 25 | 2018 | 18415 | 0.440 |
Why?
|
| Aged, 80 and over | 16 | 2018 | 6509 | 0.440 |
Why?
|
| Reproducibility of Results | 19 | 2012 | 2705 | 0.440 |
Why?
|
| Communication | 1 | 2016 | 441 | 0.430 |
Why?
|
| Chickens | 4 | 2021 | 212 | 0.430 |
Why?
|
| Lung Diseases | 5 | 2007 | 263 | 0.410 |
Why?
|
| Ethics, Research | 1 | 2012 | 52 | 0.400 |
Why?
|
| Radiology Information Systems | 1 | 2012 | 76 | 0.400 |
Why?
|
| Japan | 6 | 2016 | 307 | 0.400 |
Why?
|
| Ultrasonography, Mammary | 1 | 2012 | 82 | 0.400 |
Why?
|
| Mammary Glands, Human | 1 | 2011 | 22 | 0.390 |
Why?
|
| Patients | 1 | 2012 | 100 | 0.390 |
Why?
|
| Health Physics | 3 | 2024 | 18 | 0.390 |
Why?
|
| Radiography | 3 | 2022 | 813 | 0.380 |
Why?
|
| Logistic Models | 1 | 2014 | 1186 | 0.380 |
Why?
|
| Anniversaries and Special Events | 2 | 2022 | 14 | 0.380 |
Why?
|
| Computer Terminals | 2 | 2010 | 7 | 0.370 |
Why?
|
| Gastrointestinal Tract | 1 | 2012 | 191 | 0.360 |
Why?
|
| Female | 34 | 2020 | 44532 | 0.350 |
Why?
|
| Middle Aged | 21 | 2018 | 25028 | 0.320 |
Why?
|
| Clinical Competence | 6 | 2011 | 751 | 0.300 |
Why?
|
| Brain Neoplasms | 1 | 2013 | 763 | 0.300 |
Why?
|
| Area Under Curve | 4 | 2019 | 334 | 0.300 |
Why?
|
| Diagnosis, Differential | 11 | 2016 | 1565 | 0.280 |
Why?
|
| Male | 25 | 2020 | 40965 | 0.280 |
Why?
|
| Contrast Media | 7 | 2016 | 1078 | 0.270 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2023 | 20 | 0.240 |
Why?
|
| Genotype | 2 | 2019 | 1851 | 0.230 |
Why?
|
| Research | 3 | 2016 | 253 | 0.230 |
Why?
|
| Lung Diseases, Interstitial | 5 | 2011 | 235 | 0.220 |
Why?
|
| Databases, Factual | 4 | 2015 | 814 | 0.200 |
Why?
|
| History, 20th Century | 2 | 2022 | 312 | 0.200 |
Why?
|
| Citrulline | 1 | 2021 | 10 | 0.200 |
Why?
|
| Heat Stress Disorders | 1 | 2021 | 11 | 0.200 |
Why?
|
| Adult | 14 | 2018 | 25648 | 0.200 |
Why?
|
| Artifacts | 2 | 2013 | 244 | 0.190 |
Why?
|
| Mass Screening | 1 | 2005 | 618 | 0.190 |
Why?
|
| Organizations | 1 | 2020 | 17 | 0.180 |
Why?
|
| Liver | 3 | 2010 | 1230 | 0.180 |
Why?
|
| Young Adult | 3 | 2018 | 5976 | 0.180 |
Why?
|
| Matched-Pair Analysis | 1 | 2019 | 43 | 0.170 |
Why?
|
| Automation | 2 | 2018 | 106 | 0.170 |
Why?
|
| Adolescent | 3 | 2018 | 8981 | 0.170 |
Why?
|
| Spine | 1 | 2019 | 102 | 0.160 |
Why?
|
| History, 21st Century | 1 | 2019 | 175 | 0.160 |
Why?
|
| X-Ray Intensifying Screens | 1 | 2017 | 32 | 0.160 |
Why?
|
| Computers | 2 | 2016 | 112 | 0.150 |
Why?
|
| Abdomen | 1 | 2018 | 122 | 0.150 |
Why?
|
| Software Design | 1 | 2017 | 17 | 0.150 |
Why?
|
| Psychophysics | 2 | 2008 | 80 | 0.150 |
Why?
|
| Survival Analysis | 1 | 2021 | 1538 | 0.150 |
Why?
|
| Referral and Consultation | 1 | 2020 | 328 | 0.150 |
Why?
|
| Spinal Fractures | 2 | 2008 | 75 | 0.140 |
Why?
|
| X-Rays | 1 | 2016 | 130 | 0.140 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2019 | 137 | 0.140 |
Why?
|
| Neoplasm Metastasis | 2 | 2013 | 1056 | 0.140 |
Why?
|
| Pattern Recognition, Visual | 2 | 2008 | 151 | 0.140 |
Why?
|
| Conflict of Interest | 1 | 2016 | 67 | 0.130 |
Why?
|
| Stroke, Lacunar | 1 | 2015 | 4 | 0.130 |
Why?
|
| Risk Management | 1 | 2015 | 43 | 0.130 |
Why?
|
| Prognosis | 2 | 2021 | 3679 | 0.130 |
Why?
|
| Osteoporosis | 2 | 2006 | 121 | 0.130 |
Why?
|
| Transcriptome | 1 | 2019 | 580 | 0.120 |
Why?
|
| Angiography | 1 | 2015 | 208 | 0.120 |
Why?
|
| Societies, Medical | 2 | 2016 | 572 | 0.120 |
Why?
|
| False Positive Reactions | 4 | 2007 | 216 | 0.120 |
Why?
|
| Child | 2 | 2017 | 6927 | 0.120 |
Why?
|
| Sex Differentiation | 1 | 2013 | 9 | 0.110 |
Why?
|
| Chimera | 1 | 2013 | 56 | 0.110 |
Why?
|
| Prospective Studies | 2 | 2011 | 4213 | 0.110 |
Why?
|
| Liquid Crystals | 2 | 2011 | 12 | 0.110 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 2011 | 10 | 0.100 |
Why?
|
| Radiology Department, Hospital | 1 | 2012 | 27 | 0.100 |
Why?
|
| Hematologic Diseases | 1 | 2011 | 79 | 0.100 |
Why?
|
| Reproduction | 1 | 2013 | 195 | 0.100 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2012 | 106 | 0.100 |
Why?
|
| Ultrasonography, Interventional | 1 | 2011 | 121 | 0.100 |
Why?
|
| Taste Buds | 1 | 2010 | 1 | 0.090 |
Why?
|
| Radiopharmaceuticals | 1 | 2011 | 180 | 0.090 |
Why?
|
| Positron-Emission Tomography | 1 | 2011 | 329 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 1 | 2012 | 353 | 0.090 |
Why?
|
| Expert Systems | 1 | 2009 | 18 | 0.090 |
Why?
|
| Colorectal Neoplasms | 2 | 2008 | 938 | 0.090 |
Why?
|
| Lung | 5 | 2006 | 1170 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2016 | 2261 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 297 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 636 | 0.080 |
Why?
|
| Confidence Intervals | 1 | 2009 | 229 | 0.080 |
Why?
|
| Movement | 1 | 2011 | 299 | 0.080 |
Why?
|
| Professional Competence | 1 | 2008 | 68 | 0.080 |
Why?
|
| Microbubbles | 1 | 2008 | 36 | 0.080 |
Why?
|
| Liver Cirrhosis | 1 | 2010 | 297 | 0.080 |
Why?
|
| Medical Oncology | 2 | 2008 | 359 | 0.080 |
Why?
|
| Colonography, Computed Tomographic | 1 | 2008 | 81 | 0.080 |
Why?
|
| Periodicals as Topic | 1 | 2009 | 168 | 0.080 |
Why?
|
| Bone Diseases | 1 | 2007 | 54 | 0.080 |
Why?
|
| Animals | 4 | 2021 | 26582 | 0.070 |
Why?
|
| Fractures, Compression | 1 | 2006 | 17 | 0.070 |
Why?
|
| Principal Component Analysis | 2 | 2018 | 155 | 0.070 |
Why?
|
| Task Performance and Analysis | 1 | 2006 | 86 | 0.070 |
Why?
|
| Aging | 1 | 2011 | 691 | 0.070 |
Why?
|
| Nerve Net | 2 | 2008 | 366 | 0.070 |
Why?
|
| Review Literature as Topic | 2 | 2018 | 21 | 0.070 |
Why?
|
| Models, Statistical | 2 | 2006 | 574 | 0.070 |
Why?
|
| Child, Preschool | 1 | 2012 | 3612 | 0.060 |
Why?
|
| Tomography, Spiral Computed | 1 | 2004 | 76 | 0.060 |
Why?
|
| Insurance, Health | 1 | 2005 | 160 | 0.060 |
Why?
|
| Thoracic Neoplasms | 1 | 2003 | 64 | 0.060 |
Why?
|
| Physics | 1 | 2023 | 22 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2005 | 454 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2011 | 1075 | 0.050 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2005 | 275 | 0.050 |
Why?
|
| Retrospective Studies | 5 | 2016 | 8489 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 2438 | 0.050 |
Why?
|
| United States | 3 | 2012 | 6672 | 0.050 |
Why?
|
| Hormones | 1 | 2021 | 141 | 0.050 |
Why?
|
| Hot Temperature | 1 | 2021 | 206 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2021 | 684 | 0.040 |
Why?
|
| Atrophy | 1 | 2018 | 117 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 2018 | 129 | 0.040 |
Why?
|
| Breast | 1 | 2019 | 288 | 0.040 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 132 | 0.030 |
Why?
|
| Early Detection of Cancer | 2 | 2011 | 394 | 0.030 |
Why?
|
| International Cooperation | 1 | 2016 | 127 | 0.030 |
Why?
|
| Interprofessional Relations | 1 | 2016 | 121 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2016 | 357 | 0.030 |
Why?
|
| Semen | 1 | 2013 | 13 | 0.030 |
Why?
|
| Ovulation | 1 | 2013 | 68 | 0.030 |
Why?
|
| Sexual Maturation | 1 | 2013 | 35 | 0.030 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2013 | 50 | 0.030 |
Why?
|
| Luteinizing Hormone | 1 | 2013 | 167 | 0.030 |
Why?
|
| Spermatozoa | 1 | 2013 | 62 | 0.030 |
Why?
|
| Chick Embryo | 1 | 2013 | 229 | 0.030 |
Why?
|
| Neurotransmitter Agents | 1 | 2013 | 106 | 0.030 |
Why?
|
| Estradiol | 1 | 2013 | 252 | 0.030 |
Why?
|
| Reference Standards | 1 | 2012 | 159 | 0.030 |
Why?
|
| Punctures | 1 | 2011 | 29 | 0.030 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2011 | 172 | 0.020 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2011 | 176 | 0.020 |
Why?
|
| Carboplatin | 1 | 2011 | 286 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2013 | 319 | 0.020 |
Why?
|
| Quinine | 1 | 2010 | 6 | 0.020 |
Why?
|
| Taste Perception | 1 | 2010 | 4 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2011 | 237 | 0.020 |
Why?
|
| Food Preferences | 1 | 2010 | 26 | 0.020 |
Why?
|
| Neurons | 2 | 2013 | 1546 | 0.020 |
Why?
|
| Taste | 1 | 2010 | 28 | 0.020 |
Why?
|
| Portal Vein | 1 | 2010 | 120 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2013 | 373 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2011 | 460 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2010 | 235 | 0.020 |
Why?
|
| Cisplatin | 1 | 2011 | 612 | 0.020 |
Why?
|
| Software Validation | 1 | 2008 | 3 | 0.020 |
Why?
|
| Species Specificity | 1 | 2010 | 678 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2008 | 131 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 865 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 971 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 1673 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2008 | 912 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2006 | 369 | 0.020 |
Why?
|
| Information Storage and Retrieval | 1 | 2005 | 120 | 0.020 |
Why?
|
| Mobile Health Units | 1 | 2003 | 11 | 0.010 |
Why?
|
| Radiology, Interventional | 1 | 2004 | 68 | 0.010 |
Why?
|
| Quality Control | 1 | 2003 | 117 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2005 | 839 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2004 | 1805 | 0.010 |
Why?
|